Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Neos Therapeutics, Inc. (NEOS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/12/2021 |
GN
| Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience |
| 02/10/2021 |
GN
| Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021 |
| 12/11/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Neos Therapeutics, Inc. Merger |
| 12/10/2020 |
GN
| Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company |
| 11/02/2020 |
GN
| Neos Therapeutics to Host Third Quarter 2020 Financial and Operating Results Conference Call on November 9th, 2020 |
| 08/03/2020 |
GN
| Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 2020 |
| 05/26/2020 |
GN
| Neos Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference |
| 03/06/2020 |
GN
| Neos Therapeutics to Host Fourth Quarter and Year-End 2019 Financial and Operating Results Conference Call on March 13th, 2020 |
| 11/08/2019 |
GN
| Neos Therapeutics Reports Third Quarter 2019 Financial Results |
| 11/01/2019 |
GN
| Neos Therapeutics to Host Third Quarter 2019 Financial and Operating Results Conference Call on November 8, 2019 |
| 09/25/2019 |
GN
| Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference |
| 06/12/2019 |
GN
| Neos Therapeutics to Present at Two Upcoming June Conferences |
| 05/02/2019 |
GN
| Neos Therapeutics to Host First Quarter 2019 Financial and Operating Results Conference Call on May 9th, 2019 |
| 03/07/2019 |
GN
| Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019 |
| 02/26/2019 |
GN
| Report: Exploring Fundamental Drivers Behind Iamgold, Malibu Boats, Renren, 58, Neos Therapeutics, and Kimball Electronics — New Horizons, Emerging Trends, and Upcoming Developments |
| 12/26/2018 |
GN
| Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation |
| 11/30/2018 |
GN
| Neos Therapeutics Announces Realignment of Commercial Organization |
| 11/27/2018 |
GN
| Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer |
| 11/06/2018 |
GN
| Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock |
| 11/05/2018 |
GN
| Neos Therapeutics Announces Proposed Offering of Common Stock |
| 11/02/2018 |
GN
| Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018 |
| 10/16/2018 |
GN
| New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 09/26/2018 |
GN
| Neos Therapeutics to Present at the Cantor Global Healthcare Conference |
| 08/29/2018 |
GN
| Neos Therapeutics to Present at the Wells Fargo Healthcare Conference |
| 08/15/2018 |
GN
| Detailed Research: Economic Perspectives on Neos Therapeutics, Federated National Holding, FutureFuel, Golden Entertainment, Intra-Cellular Therapies, and HTG Molecular Diagnostics — What Drives Growth in Today's Competitive Landscape |
| 06/27/2018 |
GN
| Neos Therapeutics Appoints Jerry McLaughlin as Chief Executive Officer |
| 05/31/2018 |
GN
| Neos Therapeutics to Participate in Two June Conferences |
| 05/09/2018 |
GN
| Neos Therapeutics Reports First Quarter 2018 Financial Results |
| 05/02/2018 |
GN
| Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018 |
| 05/01/2018 |
GN
| Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 03/15/2018 |
GN
| Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results |
| 02/26/2018 |
GN
| Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older |
| 01/10/2018 |
GN
| Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting |
| 11/28/2017 |
GN
| Neos Therapeutics to Participate in Two December Conferences |
|
|
|